Cue Biopharma, Inc. (CUE) Q4 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cue Biopharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.851 Greetings, and welcome to the QBioPharma fourth quarter and full year 2022 earnings call. 00:00:05.851 -- 00:00:08.832 At this time, all participants are in a listen-only mode. 00:00:08.832 -- 00:00:12.373 A question and answer session will follow the formal presentation. 00:00:12.373 -- 00:00:16.234 If anyone were to require operator assistance during the conference, please press star 00:00:16.234 -- 00:00:21.415 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:21.415 -- 00:00:23.876 I would now like to turn the conference over to your host, Mr. 00:00:23.876 -- 00:00:28.737 Dan Passeri, Chief Executive Officer. Please go ahead. 00:00:28.757 -- 00:00:31.638 Yeah, thank you, and good afternoon, everyone. 00:00:31.638 -- 00:00:35.439 As a reminder, this conference will be recorded and available on our website for the 00:00:35.439 -- 00:00:40.841 next 30 days. Also, as a reminder, those listening in, just be aware of the webcast. 00:00:40.841 -- 00:00:46.003 You need to advance the slides as you are listening, and we'll notify you which slide 00:00:46.003 -- 00:00:50.704 we're on at a given time. Joining me on today's call 00:00:50.704 -- 00:00:54.606 is Dr. Matteo Levesetti, our Chief Medical Officer, Dr. 00:00:54.606 -- 00:00:59.877 Ken Pienta, now in the role as Clinical Advisory Cue, Dr. 00:00:59.877 -- 00:01:05.301 Anish Suri, our President and Chief Scientific Officer, and Kerry Millar, 00:01:05.301 -- 00:01:10.185 our Chief Financial Officer. Also joining us briefly on today's call is Dr. 00:01:10.185 -- 00:01:15.390 Sarah Pei, Surgical Oncologist and Director of Translational Head and Neck Cancer Research 00:01:15.390 -- 00:01:21.235 at the Mass General Hospital. She's an investigator on o...